Search company, investor...
Dr. Reddy's Laboratories company logo

Dr. Reddy's Laboratories

Founded Year



Corporate Minority - P2P | IPO

Market Cap


Stock Price


About Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) is an integrated pharmaceuticals company. Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy's Laboratories was founded in 1984 and is based in Hyderabad, India.

Headquarters Location

Door No 8-2-337 Road No 3, Banjara Hills

Hyderabad, 500 034,



Missing: Dr. Reddy's Laboratories's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Dr. Reddy's Laboratories's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Dr. Reddy's Laboratories

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Dr. Reddy's Laboratories is included in 1 Expert Collection, including Cancer.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Dr. Reddy's Laboratories Patents

Dr. Reddy's Laboratories has filed 216 patents.

The 3 most popular patent topics include:

  • Fluoroarenes
  • Amines
  • Clusters of differentiation
patents chart

Application Date

Grant Date


Related Topics




Ion channel toxins, Immunology, Neurotoxins, Invertebrate toxins, Equilibrium chemistry


Application Date


Grant Date



Related Topics

Ion channel toxins, Immunology, Neurotoxins, Invertebrate toxins, Equilibrium chemistry



Latest Dr. Reddy's Laboratories News

UPS Adds Over 200 Flights in April to Support Project Airbridge Coronavirus Relief Efforts

Apr 21, 2020

UPS India helped Dr. Reddys Laboratories ship critical compounds for essential medicines to the United States UPS (NYSE:UPS) said it has added over 200 company-owned and chartered air freighter flights in April to support FEMA’s Project Airbridge and other healthcare-related missions. Project Airbridge is a public-private partnership to get vital and life-saving equipment to where it is needed with greater speed. These additional flights serve to meet the soaring demand to ship test kits, personal protective equipment and other supplies necessary for the global response effort. “With our scale and flexible global network, we are in a unique position to handle Coronavirus response shipments for FEMA and healthcare customers,” said David Abney, UPS Chairman and CEO. “In these uncertain times, our customers depend on us more than ever. Our employees are keeping America moving and meeting the urgent needs created by the pandemic. We will continue to serve and do our part to lead in the fight against COVID-19.” The vast majority of the additional flights are carrying products from Asia to the U.S. and Europe. UPS is shipping personal protective equipment, ventilators, emergency room monitoring equipment, Coronavirus test kits and other supplies. The company is also proud to have the capabilities to transport specialized products, such as temperature sensitive compounds. A recent flight for Dr. Reddy’s Laboratories Ltd., a major Indian pharmaceutical company, originated in Hyderabad, India and contained 30 tons of temperature-sensitive compounds to be shipped to the U.S. on an urgent basis. To maintain product effectiveness, the entire shipment had to be maintained at +15C – +25C. The product was moved within the UPS network through the Cologne, Germany air hub, then to the UPS Worldport in Kentucky, before reaching its final destination on time and as promised. About UPS UPS (NYSE: UPS) is a global leader in logistics, offering a broad range of solutions including transporting packages and freight; facilitating international trade, and deploying advanced technology to more efficiently manage the world of business. Headquartered in Atlanta, UPS serves more than 220 countries and territories worldwide. UPS was awarded America’s Best Customer Service company for Shipping and Delivery services by Newsweek magazine; Forbes Most Valuable Brand in Transportation; and top rankings on the JUST 100 list for social responsibility, the Dow Jones Sustainability World Index, and the Harris Poll Reputation Quotient, among other prestigious rankings and awards. The company can be found on the web at or and its corporate blog can be found at The company’s sustainability eNewsletter, UPS Horizons, can be found at To get UPS news direct, follow @UPS_News on Twitter. To ship with UPS, please visit ~ Newsvoir Posted in

Dr. Reddy's Laboratories Frequently Asked Questions (FAQ)

  • When was Dr. Reddy's Laboratories founded?

    Dr. Reddy's Laboratories was founded in 1984.

  • Where is Dr. Reddy's Laboratories's headquarters?

    Dr. Reddy's Laboratories's headquarters is located at Door No 8-2-337, Hyderabad.

  • What is Dr. Reddy's Laboratories's latest funding round?

    Dr. Reddy's Laboratories's latest funding round is Corporate Minority - P2P.

  • Who are the investors of Dr. Reddy's Laboratories?

    Investors of Dr. Reddy's Laboratories include Life Insurance Corporation of India.

  • Who are Dr. Reddy's Laboratories's competitors?

    Competitors of Dr. Reddy's Laboratories include Sun Pharma and 4 more.

Compare Dr. Reddy's Laboratories to Competitors

Limbix Logo

Limbix delivers mental health treatment to young people. It offers digital therapeutic for adolescent depression, enabling doctors to provide digital, evidence-based, therapeutic interventions, behavioral health care, and more. The company was founded in 2016 and is based in San Francisco, California.


Ranbaxy is a pharmaceutical distributor.

Cipla Logo

Cipla (BSE: 500087) (NSE: CIPLA) is a multinational pharmaceutical and biotechnology company. Cipla primarily develops medicines to treat cardiovascular disease, arthritis, diabetes, weight control, and depression, as well as other medical conditions.

Aurobindo Pharma Logo
Aurobindo Pharma

Aurobindo Pharma (NSE: AUROPHARMA) manufactures pharmaceutical products, which include anti-retroviral medicines, antibiotics, gastroenterological medicines, anti-diabetics medicines, anti-allergic medicines, etc. Apart from Pharmaceutical businesses, it also caters to drug formulation. The company was founded in 1986 and is based in Telangana, India.

Sun Pharma Logo
Sun Pharma

Sun Pharma (NSE: SUNPHARMA, BSE: 524715) is an international specialty pharmaceutical company. It manufactures and markets pharmaceutical formulations as branded generics. The company’s portfolio includes products for the treatment of psychiatric, neurological, nephrological, gastroenterological, orthopedic, ophthalmologic diseases and disorders, and heart diseases. The company was founded in 1983 and is based in Mumbai, India.

Lupin Logo

Lupin (NSE: LUPIN) is a transnational pharmaceutical company producing and developing branded and generic formulations and active pharmaceutical ingredients (APIs). It focuses on generics, biosimilars, and tech-driven offerings. The company was founded in 1983 and is based in Mumbai, India.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.